ENDED on 31/03/17 but open ONLY FOR ARCHIVING AND PUBLISHING COST .(EPIVIN) - Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia

Project: Other Government Departments

Participants

Colleges, School and Institutes

Short titleENDED on 31/03/17 but open ONLY FOR ARCHIVING AND PUBLISHING COST .(EPIVIN) - Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia
StatusFinished
Effective start/end date1/04/1431/12/20